Also, the resumption of some production at Equinor's (EQNR) Johan Sverdrup field in the North Sea after an outage yesterday ...

In October 2024, Topas Therapeutics announced positive topline results from its Phase IIa trial of TPM502, in patients with celiac disease. The study data serves as the first clinical proof of concept ...

The Dark Energy Spectroscopic Instrument (DESI) is a cutting-edge telescope that captures the light from millions of galaxies ...